Yahoo India Web Search

  1. Ad

    related to: concord biotech ipo
  2. The 2024 IPO lineup includes a company that could be one the biggest of all time. Recession fears are fading. Now is the time to invest in IPOs. We reveal the top 5 - free.

Search results

  1. Concord Biotech IPO is a book built issue of Rs 1,551 crores, entirely an offer for sale of 2.09 crore shares. The issue was open for subscription from August 4 to 8, 2023 and listed on BSE, NSE on August 18, 2023.

    • August 8, 2023
    • 1482-86, Trasad Road Dholka, Gujarat
    • August 4, 2023
  2. Aug 18, 2023 · Concord Biotech is an R&D-driven biopharma company that offers APIs and formulations. It plans to raise ₹1551 crores via IPO on August 4-8, 2023. See IPO review, price band, allotment status, and more.

    • August 8, 2023
    • Approx ₹1551 Crores
    • August 4, 2023
    • Approx 20,925,652 Equity Shares
  3. Aug 1, 2023 · Concord Biotech is a biopharma company that develops and manufactures fermentation-based APIs. It plans to raise ₹ 1,551 crore from an OFS of 2,09,25,652 shares in August 2023. See the issue details, latest GMP, price band, financials and more.

    • 011 6656 1234
    • customersupport@livemint.com
  4. Aug 4, 2023 · Concord Biotech IPO: The initial public offering (IPO) of Concord Biotech Limited has opened today for subscribers and it will remain open for bidders till 8th August 2023. The public issue aims...

    • 011 6656 1234
    • customersupport@livemint.com
  5. Aug 8, 2023 · Concord Biotech IPO: The initial public offering (IPO) opened for bidding on 4th August 2023 and its subscription will end on 8th August 2023. This means, today is the last date to apply...

    • 011 6656 1234
    • customersupport@livemint.com
  6. Aug 7, 2023 · Check the latest subscription status, shares offered, and investor categories of Concord Biotech IPO, a public issue of 20,925,652 equity shares. The issue subscribed 24.87 times by August 8, 2023 (Day 3).

  7. Aug 1, 2023 · Concord Biotech is a biopharma company that manufactures select fermentation-based APIs across immunosuppressants and oncology. The IPO opens on August 4 and closes on August 8, with a price band of Rs 705-741 per share.

  1. Searches related to concord biotech ipo

    tvs supply chain ipo
    mankind pharma ipo
    sbfc finance ipo
  1. People also search for